STAT | A decade of reporting from the frontiers of health and medicine

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

July 24, 2026

STAT Plus: Up and down the ladder: The latest comings and goings
July 24, 2026

STAT Plus: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
July 24, 2026

I may be one of the last middle-class medical students who could afford to become a doctor
July 24, 2026

The U.S. pharmaceutical supply chain problem is not about China
July 23, 2026

STAT Plus: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
July 23, 2026

U.S. health officials are investigating a new outbreak of a diarrhea-causing parasite

Test your knowledge with our now weekday mini crossword

Play the STAT Mini

Out of Pocket, Out of Reach: Why has employer-based health insurance become so unaffordable?

Read the series

FDA advisory panel narrowly rejects compounding of one peptide, backs two others

The meeting highlighted tensions between RFK Jr.’s MAHA movement and mainstream science

Health July 24, 2026

There are already more U.S. measles cases this year than in all of 2025

First Opinion July 24, 2026

I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak

Politics July 24, 2026

STAT Plus: White House offers its science blueprint: More AI, less life sciences

Health July 24, 2026

Senate advances MAHA-friendly bill for food warning labels and junk food ad bans

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides

STAT Plus: ‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027

STAT Plus: White House offers its science blueprint: More AI, less life sciences

STAT Plus: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changer

STAT Plus: Fatal gene-editing trial in China raises ethics and oversight questions

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

Office Hours with Isabella Cueto and Lev Facher

Virtual

Office Hours with STAT's Isabella Cueto and Lev Facher on their series 'Deadliest Drug,' a look at the health issues caused by alcohol.

2026 STAT Summit

Boston, MA

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

Chaotic and politicized: Inside the FDA under Trump

$49

Explore how turmoil and political pressure have destabilized the agency with mass layoffs, rapid staff departures, and a revolving door of leadership.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

A weekly interview show featuring the most interesting people and ideas in medicine.

Color Code

Enjoy the archives of Color Code, our podcast on racial inequities in American health care.

More From STAT

View upcoming events Play the STAT Mini Crossword Explore trackers Download our latest Report Listen to STAT podcasts

More Stories

Pharmalot July 24, 2026

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot July 24, 2026

STAT Plus: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill

First Opinion July 24, 2026

I may be one of the last middle-class medical students who could afford to become a doctor

First Opinion July 24, 2026

The U.S. pharmaceutical supply chain problem is not about China

Biotech July 23, 2026

STAT Plus: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides

Health July 23, 2026

U.S. health officials are investigating a new outbreak of a diarrhea-causing parasite

Pharmalot July 23, 2026

STAT Plus: European regulators take steps to bolster clinical trial transparency

Health July 23, 2026

STAT Plus: Popular insulin product enters shortage as other pens leave market

Health July 23, 2026

Senate health panel delays vote on CDC nominee

The Readout LOUD July 23, 2026

A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing

Health July 23, 2026

STAT Plus: Vote on key federal health nominee delayed amid questions over vaccine views

Health July 23, 2026

STAT Plus: Trump administration quietly picks Timothy Westlake to lead mental health agency

The Readout July 24, 2026

STAT Plus: Fatal gene-editing trial in China raises ethics and oversight questions

Pharmalot July 24, 2026

STAT Plus: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more

D.C. Diagnosis July 23, 2026

STAT Plus: What’s in the last-minute flurry of health care bills?

Pharmalot July 23, 2026

STAT Plus: Pharmalittle: We’re reading about Lilly obesity drug data, a push for FDA to ban DTC ads, and more

Health Tech Newsletter July 23, 2026

STAT Plus: HHS to convene experts on standards for clinical AI

Pharma July 23, 2026

STAT Plus: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit

First Opinion July 24, 2026

I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak

First Opinion July 24, 2026

I may be one of the last middle-class medical students who could afford to become a doctor

First Opinion July 24, 2026

The U.S. pharmaceutical supply chain problem is not about China

First Opinion July 23, 2026

New billing codes likely to raise maternity care costs

First Opinion July 23, 2026

Good riddance to bundled ‘global’ maternal care billing

First Opinion July 22, 2026

What Argentina’s World Cup loss should teach American hospitals

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

How America’s employer-based health care system continues to crumble in slow motion

12 ideas for tackling the U.S. alcohol epidemic

By Isabella Cueto and Lev Facher

STAT Plus: Under a new leader, the FDA’s biologics center moves to steady itself after stormy chapter

By Lizzy Lawrence

Flood of comments on White House grantmaking overhaul is largely negative, analysis shows

By Anil Oza and J. Emory Parker

STAT Plus: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals

STAT Plus: Can ultrasound unlock the power of gene therapy? A startup makes big claims

STAT Plus: MDCalc is scoring the clinical calculators used by millions of doctors

By Katie Palmer

STAT Plus: The quest to save Grace — and clear the way for rare disease patients everywhere

By Jason Mast and Matthew Herper

STAT Plus: Broad Institute, partners unveil new initiative to develop gene therapies for rare diseases

Biotech July 21, 2026

STAT Plus: Broad Institute, partners unveil new initiative to develop gene therapies for rare diseases

Biotech July 16, 2026

STAT Plus: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley

Biotech July 15, 2026

STAT Plus: A new biotech startup tries to tackle obesity, but not in the way you might expect

STAT Plus: Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and more

Pharmalot July 22, 2026

STAT Plus: Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and more

Pharmalot July 21, 2026

STAT Plus: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and more

Pharmalot July 21, 2026

STAT Plus: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’

New study supports testing of Merck’s Ebola vaccine in DRC outbreak

Health July 22, 2026

New study supports testing of Merck’s Ebola vaccine in DRC outbreak

Health July 22, 2026

Congo’s Ebola outbreak has killed over 1,000 people

Health July 22, 2026

As Maui recovers from devastating fires, a study offers vision for new rural health model

STAT Plus: Trump promised redemption for troops who refused Covid shots. A year later, many are still waiting

Politics July 23, 2026

STAT Plus: Trump promised redemption for troops who refused Covid shots. A year later, many are still waiting

Politics July 23, 2026

STAT Plus: FDA staff and peptide enthusiasts set to clash at advisory panel

Politics July 22, 2026

STAT Plus: Federal health quality research grants worth $109 million ended early

Video

What happens on ‘MAHA Monday’?

What does content creation do to mental health?

BIO 2026: AI, federal policy impacts, and general vibes

What’s next for GLP-1 weight loss drugs?

STAT Plus: Nabla’s new CEO on plan to gain market share in a competitive AI scribe environment

Health tech July 21, 2026

STAT Plus: Nabla’s new CEO on plan to gain market share in a competitive AI scribe environment

Health tech July 16, 2026

STAT Plus: CMS signals intent to revamp how it pays for clinical software and AI

Health tech July 15, 2026

STAT Plus: In a major policy shift, Medicare proposes to ban vendors from providing remote monitoring services

STAT Plus: Brain implant restores the sensation of touch in a person with quadriplegia

In the Lab July 16, 2026

STAT Plus: Brain implant restores the sensation of touch in a person with quadriplegia

In the Lab July 15, 2026

STAT Plus: New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosis

In the Lab July 1, 2026

STAT Plus: Synthetic biology researchers think they’ve made a cell. Is it alive?

STAT Plus: Mass General Brigham, nurses called to talk at State House amid biggest nursing strike in Mass.

Hospitals July 8, 2026

STAT Plus: Mass General Brigham, nurses called to talk at State House amid biggest nursing strike in Mass.

Hospitals June 24, 2026

Judge temporarily blocks subpoenas in criminal probe of transgender care at New York hospitals

Hospitals April 14, 2026

STAT Plus: Dana-Farber CEO talks untangling from Mass General Brigham and building new cancer hospital

STAT Plus: More workers hate their jobs, but keep them for the health insurance

Insurance July 22, 2026

STAT Plus: More workers hate their jobs, but keep them for the health insurance

Insurance July 16, 2026

STAT Plus: Despite earnings celebration, UnitedHealth signals more financial pain for employers

Insurance July 15, 2026

STAT Plus: Elevance plots a Medicaid retreat as costs remain high

Podcasts

Whistleblower takes on health insurance and FDA commissioner candidates

The mysterious case of Eli Lilly’s obesity drug

How STAT decided to keep ‘health care’ as two words

STAT Plus: An obesity drug deep-dive, and peptides move mainstream